Viewing Study NCT04985266


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-02 @ 12:33 AM
Study NCT ID: NCT04985266
Status: RECRUITING
Last Update Posted: 2024-12-05
First Post: 2021-06-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Sponsor: Royal Marsden NHS Foundation Trust
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CCR5316
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None OTHER View
None OTHER View
None OTHER View
None INDUSTRY View